Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01531439 · ClinicalTrials.gov registry record · NA

Comparison of Two Naloxone Infusion Rates on the Postoperative Recovery of Patients Undergoing Spine Fusion Surgery

A NA study, sponsored by Children's Mercy Hospital Kansas City.

Completed
Registry status
NA
Development phase
84
Enrollment target

NCT01531439 is a NA study that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 84 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01531439, a NA study, has completed, sponsored by Children's Mercy Hospital Kansas City.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target

Study Summary

There will be two groups in this study: one group will be given the standard infusion of naloxone, a drug which helps reduce side effects from opioids needed after surgery, and the other group will receive a higher dose. The trial is designed to determine if a higher dose of naloxone infusion will reduce side effects from opioid therapy in patients who have undergone spine fusion for scoliosis.

Interventions

  • DRUG Naloxone

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2011-11
Est. Completion 2016-12-01
Phase NA

What the Registry Record Tells You About NCT01531439

The ClinicalTrials.gov registry entry for NCT01531439 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Naloxone is the first listed.

NCT01531439 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01531439 about?

NCT01531439 is a clinical study titled "Comparison of Two Naloxone Infusion Rates on the Postoperative Recovery of Patients Undergoing Spine Fusion Surgery". There will be two groups in this study: one group will be given the standard infusion of naloxone, a drug which helps reduce side effects from opioids needed after surgery, and the other group will receive a higher dose. The trial is designed to determine if a higher dose of naloxone infusion will r...

What is the current status of trial NCT01531439?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2011-11. Estimated completion is 2016-12-01.

What interventions are being tested in trial NCT01531439?

The interventions under investigation include: Naloxone (DRUG).

Who is sponsoring clinical trial NCT01531439?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.